Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Open Access

Issue Information

  • Pages: 165-167
  • First Published: 20 March 2024

REVIEW ARTICLES

Open Access

Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease

Hannes Hagström,  Hannes Hegmar,  Christophe Moreno, 
  • Pages: 168-176
  • First Published: 21 February 2024
Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease

Open Access

Therapeutic management of metabolic dysfunction associated steatotic liver disease

Jing Zeng,  Jian-Gao Fan,  Sven M. Francque, 
  • Pages: 177-186
  • First Published: 09 January 2024
Therapeutic management of metabolic dysfunction associated steatotic liver disease

Open Access

The assessment and management of cirrhotic patients with encephalopathy

H. Kibble,  Debbie L. Shawcross, 
  • Pages: 187-193
  • First Published: 05 January 2024
The assessment and management of cirrhotic patients with encephalopathy

Open Access

Acute decompensation of cirrhosis versus acute-on-chronic liver failure: What are the clinical implications?

Manman Xu,  Yu Chen,  Florent Artru, 
  • Pages: 194-202
  • First Published: 20 February 2024
Acute decompensation of cirrhosis versus acute-on-chronic liver failure: What are the clinical implications?

Open Access

Workup and management of liver transplantation in alcohol-related liver disease

Giacomo Germani,  Delphine Degré,  Christophe Moreno,  Patrizia Burra, 
  • Pages: 203-209
  • First Published: 08 March 2024
Workup and management of liver transplantation in alcohol-related liver disease

Open Access

Management of chronic HBV-HDV patients chronic HBV-HDV infection: A review on new management options

María Buti,  Alexia Gonzalez,  Mar Riveiro-Barciela,  Marc Bourliere, 
  • Pages: 210-218
  • First Published: 02 December 2023
Management of chronic HBV-HDV patients chronic HBV-HDV infection: A review on new management options

Open Access

Diagnosis and assessment of disease severity in patients with nonalcoholic fatty liver disease

Jie Li,  Adèle Delamarre,  Vincent Wai-Sun Wong,  Victor de Lédinghen, 
  • Pages: 219-225
  • First Published: 21 November 2023
Diagnosis and assessment of disease severity in patients with nonalcoholic fatty liver disease

Open Access

Locoregional therapies for hepatocellular carcinoma: The current status and future perspectives

Jian-Jian Chen,  Zhi-Cheng Jin,  Bin-Yan Zhong,  Wenzhe Fan,  Wei-Hua Zhang,  Biao Luo,  Yu-Qing Wang,  Gao-Jun Teng,  Hai-Dong Zhu, 
  • Pages: 226-239
  • First Published: 19 February 2024
Open Access

Exploring the links between types 2 diabetes and liver-related complications: A comprehensive review

Lukas Otero Sanchez,  Yuping Chen,  Guillaume Lassailly,  Xiaolong Qi, 
  • Pages: 240-251
  • First Published: 16 December 2023
Exploring the links between types 2 diabetes and liver-related complications: A comprehensive review

Open Access

Systemic therapies in hepatocellular carcinoma: A revolution?

Marta Fortuny,  Marco Sanduzzi-Zamparelli,  Maria Reig, 
  • Pages: 252-260
  • First Published: 24 January 2024
Systemic therapies in hepatocellular carcinoma: A revolution?

Open Access

Recent developments in the management of ascites in cirrhosis

Tian Lan,  Ming Chen,  Chengwei Tang,  Pierre Deltenre, 
  • Pages: 261-272
  • First Published: 10 February 2024